Thymosin Alpha-1
Immune / Research-only
Thymic immunomodulator for infection research.
For research use only.
Key Facts
- CAS
- 62304-98-7
- Molecular Weight (MW)
- 3108.3 g/mol
- Half-life
- ~2 hours
- Unit
- mcg
- Administration Route
- Subcutaneous
- Frequency
- Daily or 2-3x weekly
- Last updated
- 12/18/2025
- Targets
- T-cellsNK cells
Overview
Thymic immunomodulator for infection research.
Protocol
- Dosage Range
- 300-900 mcg daily or 1.6 mg 2-3x weekly
- Frequency
- Daily or 2-3x weekly
- Cycle
- 4-24 weeks on, 4-6 off
- Administration Route
- Subcutaneous
- Reconstitution Guide
- 3 mL BAC for 5 mg vial
Science
Mechanism of Action
Immune modulation, cytokine balance.
Targets
T-cellsNK cells
Studies
- — Journal/year not available
Benefits
Immune enhancementInfection resistanceInflammation reductionHealing support
Potential Side Effects
- Irritation
- Flu-like